Novo Nordisk (spons. ADRs) Aktie
49,10
EUR
+1,00
EUR
+2,08
%
57,20
USD
+0,65
USD
+1,14
%
Werbung
Novo Nordisk (spons. ADRs) Aktie Analyse
| 20.06.19 | Novo Nordisk (spons. ADRs) Hold | Deutsche Bank AG | |
| 11.06.19 | Novo Nordisk (spons. ADRs) Equal weight | Barclays Capital | |
| 26.07.12 | Novo Nordisk (spons. ADRs) neutral | Exane-BNP Paribas SA | |
| 08.06.12 | Novo Nordisk (spons. ADRs) neutral | Sarasin Research | |
| 18.05.12 | Novo Nordisk (spons. ADRs) equal-weight | Morgan Stanley | |
| 02.05.12 | Novo Nordisk (spons. ADRs) neutral | Exane-BNP Paribas SA | |
| 07.04.06 | Novo Nordisk (spons. ADRs) Hold | Deutsche Securities |
Werbung
Werbung